Skip to content

Categories: inficure bio

Sofia Mayans, CEO, and Dan Holmberg, CSO, are the co-founders of InfiCure Bio.

Strong Start to 2023 for InfiCure Bio

The life science company InfiCure Bio has started the new year in the best way by signing an agreement with a new client in the US. "The company's goal for 2023 is to increase the visibility of our NIF model by continuing our strategy to promote the model on multiple markets”

Sofia Mayans, CEO, and Dan Holmberg, CSO, are the co-founders of InfiCure Bio.

InfiCure Bio signs agreement with two major international companies

The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies. "This is yet more proof of the need for and the potential of our model" says Sofia Mayans, CEO of InciCure Bio.

Inficure Bio.

Breakthrough for Inficure Bio about liver and kidney fibrosis

Inficure Bio a life science company focused on preclinical development and validation of drugs that target chronic inflammatory and fibrotic conditions co-presented with CymaBay Therapeutics positive data at the American Association for the study of Liver Diseases (AASLD) using the company’s proprietary NIF mouse model.

We grow ideas that can change the world

Umeå Biotech Incubator (UBI) is one of Sweden’s state-of-the-art business incubators within the life sciences. We help researchers to use their data to the benefit of patients and citizens, improving their health. We support and train entrepreneurs in the fields of pharmaceuticals, diagnostics and medical engineering, and act as a bridge between academia, medicine and the business community.

Umeå Biotech Incubator
Umeå Biotech Incubator

Tvistevägen 48C
907 36 Umeå
Sweden